By Sheri Kasprzak
New York, July 15 - ReGen Biologics, Inc. said it has closed a private placement for $11,815,000.
The company sold 13.9 million shares at $0.85 each to institutional, accredited and venture investors.
The investors also received warrants for 25% of the shares sold in the offering. The warrants are exercisable at $1 each for five years.
ReGen, based in Franklin Lakes, N.J., develops tissue growth and repair products for the orthopedic-care industry.
| Issuer: | ReGen Biologics, Inc.
|
| Issue: | Stock
|
| Amount: | $11,815,000
|
| Shares: | 13.9 million
|
| Price: | $0.85
|
| Warrants: | For up to 25% of the shares issued in the offering
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $1
|
| Settlement date: | July 15 |
|
| Stock price: | $0.90 at close July 15
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
